FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2036419372> ?p ?o ?g. }

• W2036419372 endingPage "1302.e1" @default.
• W2036419372 startingPage "1297" @default.
• W2036419372 abstract "Objective To describe the successful treatment and long-term outcomes of primary ocular surface squamous neoplasia (OSSN) with topical interferon alfa-2b or surgical excision. Design Retrospective, comparative, interventional case series. Participants Twenty-nine consecutive patients with OSSN never before treated. Intervention Patients with primary OSSN chose topical interferon alfa-2b or excision with wide surgical margins, with crossover to surgery in those interferon-treated patients whose OSSN failed to regress within 2 months after beginning therapy. Main Outcome Measures Successful resolution of clinical disease at 2 months after topical interferon treatment and time to recurrence after either topical interferon or surgical excision. Results Of 29 patients with primary OSSN, 15 elected topical interferon and 14 chose surgical excision. Two patients in the interferon group subsequently underwent surgical excision for apparent lack of response to interferon. No patient in either group developed a recurrence during the study period (disease-free follow-up: interferon group, mean, 35.6 months [95% confidence interval, 21.9–49.3]; surgery group, mean, 35.6 months [22.9–48.3]). Conclusions Both topical interferon alfa-2b and aggressive surgical excision appear to be effective for primary OSSN. To describe the successful treatment and long-term outcomes of primary ocular surface squamous neoplasia (OSSN) with topical interferon alfa-2b or surgical excision. Retrospective, comparative, interventional case series. Twenty-nine consecutive patients with OSSN never before treated. Patients with primary OSSN chose topical interferon alfa-2b or excision with wide surgical margins, with crossover to surgery in those interferon-treated patients whose OSSN failed to regress within 2 months after beginning therapy. Successful resolution of clinical disease at 2 months after topical interferon treatment and time to recurrence after either topical interferon or surgical excision. Of 29 patients with primary OSSN, 15 elected topical interferon and 14 chose surgical excision. Two patients in the interferon group subsequently underwent surgical excision for apparent lack of response to interferon. No patient in either group developed a recurrence during the study period (disease-free follow-up: interferon group, mean, 35.6 months [95% confidence interval, 21.9–49.3]; surgery group, mean, 35.6 months [22.9–48.3]). Both topical interferon alfa-2b and aggressive surgical excision appear to be effective for primary OSSN." @default.
• W2036419372 created "2016-06-24" @default.
• W2036419372 creator A5003953019 @default.
• W2036419372 creator A5009981171 @default.
• W2036419372 creator A5030299442 @default.
• W2036419372 creator A5055029998 @default.
• W2036419372 date "2008-08-01" @default.
• W2036419372 modified "2023-09-23" @default.
• W2036419372 title "Topical Interferon or Surgical Excision for the Management of Primary Ocular Surface Squamous Neoplasia" @default.
• W2036419372 cites W1568451052 @default.
• W2036419372 cites W1605506735 @default.
• W2036419372 cites W1899887006 @default.
• W2036419372 cites W1964045619 @default.
• W2036419372 cites W1964349734 @default.
• W2036419372 cites W1974618327 @default.
• W2036419372 cites W1979799582 @default.
• W2036419372 cites W1981606921 @default.
• W2036419372 cites W1985772737 @default.
• W2036419372 cites W1988140811 @default.
• W2036419372 cites W1989533997 @default.
• W2036419372 cites W1991093938 @default.
• W2036419372 cites W1996765031 @default.
• W2036419372 cites W1997647595 @default.
• W2036419372 cites W2003259770 @default.
• W2036419372 cites W2010281697 @default.
• W2036419372 cites W2011721384 @default.
• W2036419372 cites W2012335974 @default.
• W2036419372 cites W2013313809 @default.
• W2036419372 cites W2020893490 @default.
• W2036419372 cites W2022627517 @default.
• W2036419372 cites W2022656532 @default.
• W2036419372 cites W2024906376 @default.
• W2036419372 cites W2025533134 @default.
• W2036419372 cites W2029974519 @default.
• W2036419372 cites W2031844429 @default.
• W2036419372 cites W2033409063 @default.
• W2036419372 cites W2033536548 @default.
• W2036419372 cites W2034287063 @default.
• W2036419372 cites W2041558443 @default.
• W2036419372 cites W2046974589 @default.
• W2036419372 cites W2048964714 @default.
• W2036419372 cites W2050169448 @default.
• W2036419372 cites W2052759121 @default.
• W2036419372 cites W2053443907 @default.
• W2036419372 cites W2056194811 @default.
• W2036419372 cites W2059191805 @default.
• W2036419372 cites W2060127000 @default.
• W2036419372 cites W2061797108 @default.
• W2036419372 cites W2062201234 @default.
• W2036419372 cites W2062453319 @default.
• W2036419372 cites W2064596299 @default.
• W2036419372 cites W2065061346 @default.
• W2036419372 cites W2067857737 @default.
• W2036419372 cites W2073693917 @default.
• W2036419372 cites W2075659930 @default.
• W2036419372 cites W2082543604 @default.
• W2036419372 cites W2087175295 @default.
• W2036419372 cites W2088480894 @default.
• W2036419372 cites W2090976995 @default.
• W2036419372 cites W2091387813 @default.
• W2036419372 cites W2094201427 @default.
• W2036419372 cites W2094647741 @default.
• W2036419372 cites W2099629617 @default.
• W2036419372 cites W2104455052 @default.
• W2036419372 cites W2105584046 @default.
• W2036419372 cites W2109877842 @default.
• W2036419372 cites W2112946802 @default.
• W2036419372 cites W2118454346 @default.
• W2036419372 cites W2127050151 @default.
• W2036419372 cites W2129831473 @default.
• W2036419372 cites W2136425577 @default.
• W2036419372 cites W2161042751 @default.
• W2036419372 cites W2165669996 @default.
• W2036419372 cites W2166262029 @default.
• W2036419372 cites W2326725409 @default.
• W2036419372 cites W57761112 @default.
• W2036419372 doi "https://doi.org/10.1016/j.ophtha.2008.01.006" @default.
• W2036419372 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18294690" @default.
• W2036419372 hasPublicationYear "2008" @default.
• W2036419372 type Work @default.
• W2036419372 sameAs 2036419372 @default.
• W2036419372 citedByCount "80" @default.
• W2036419372 countsByYear W20364193722012 @default.
• W2036419372 countsByYear W20364193722013 @default.
• W2036419372 countsByYear W20364193722014 @default.
• W2036419372 countsByYear W20364193722015 @default.
• W2036419372 countsByYear W20364193722016 @default.
• W2036419372 countsByYear W20364193722017 @default.
• W2036419372 countsByYear W20364193722018 @default.
• W2036419372 countsByYear W20364193722019 @default.
• W2036419372 countsByYear W20364193722020 @default.
• W2036419372 countsByYear W20364193722021 @default.
• W2036419372 countsByYear W20364193722022 @default.
• W2036419372 countsByYear W20364193722023 @default.
• W2036419372 crossrefType "journal-article" @default.
• W2036419372 hasAuthorship W2036419372A5003953019 @default.
• W2036419372 hasAuthorship W2036419372A5009981171 @default.
• W2036419372 hasAuthorship W2036419372A5030299442 @default.

• next